Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rian Dickstein

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Urology Practice|November 9, 2023
Editorial CommentRian Dickstein
Journal of Andrology|August 18, 2009
Severe, disabling, and/or chronic penile pain associated with Peyronie disease: management with subcutaneous steroid injectionRian Dickstein, Jayant Uberoi, Ricardo Munarriz
Nucleic Acids Research|December 1, 2009
Energetic signatures of single base bulges: thermodynamic consequences and biological implicationsConceição A S A Minetti, David P Remeta, Rian Dickstein, et al.
The Journal of Urology|August 25, 2025
Outcomes of Reinduction With Nadofaragene FiradenovecBogdana Schmidt, Joshua J Horns, Mark D Tyson, et al.
European Urology Focus|April 14, 2023
Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade DiseaseKyle M Rose, Katie S Murray, Craig Labbate, et al.
Urologic Oncology|February 2, 2024
Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trialsYair Lotan, Piyush Agarwal, Peter Black, et al.
The Journal of Urology|January 19, 2023
Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial CarcinomaCraig Labbate, Solomon Woldu, Katie Murray, et al.
European Urology Focus|August 28, 2023
Corrigendum to "Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes" [Eur. Urol. Focus (2023)]Jennifer Linehan, Josh Gottlieb, Solomon L Woldu, et al.
European Urology Focus|June 1, 2023
Route of Administration for UGN-101 and Impact on Oncological and Safety OutcomesJennifer Linehan, Josh Gottlieb, Solomon L Woldu, et al.
Urologic Oncology|May 28, 2023
The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinomaHristos Z Kaimakliotis, Isamu Tachibana, Solomon Woldu, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Urology Practice|November 9, 2023
Editorial CommentRian Dickstein
Journal of Andrology|August 18, 2009
Severe, disabling, and/or chronic penile pain associated with Peyronie disease: management with subcutaneous steroid injectionRian Dickstein, Jayant Uberoi, Ricardo Munarriz
Nucleic Acids Research|December 1, 2009
Energetic signatures of single base bulges: thermodynamic consequences and biological implicationsConceição A S A Minetti, David P Remeta, Rian Dickstein, et al.
The Journal of Urology|August 25, 2025
Outcomes of Reinduction With Nadofaragene FiradenovecBogdana Schmidt, Joshua J Horns, Mark D Tyson, et al.
European Urology Focus|April 14, 2023
Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade DiseaseKyle M Rose, Katie S Murray, Craig Labbate, et al.
Urologic Oncology|February 2, 2024
Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trialsYair Lotan, Piyush Agarwal, Peter Black, et al.
The Journal of Urology|January 19, 2023
Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial CarcinomaCraig Labbate, Solomon Woldu, Katie Murray, et al.
European Urology Focus|August 28, 2023
Corrigendum to "Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes" [Eur. Urol. Focus (2023)]Jennifer Linehan, Josh Gottlieb, Solomon L Woldu, et al.
European Urology Focus|June 1, 2023
Route of Administration for UGN-101 and Impact on Oncological and Safety OutcomesJennifer Linehan, Josh Gottlieb, Solomon L Woldu, et al.
Urologic Oncology|May 28, 2023
The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinomaHristos Z Kaimakliotis, Isamu Tachibana, Solomon Woldu, et al.
Pageof 2